NBP NovaBridge Biosciences
Nasdaq · SEC CIK 1778016 · EDGAR
- Bought, last 12 months
- $577.3K 1 purchases by 1 insiders
- Sold, last 12 months
- $154.3K 7 sales by 3 insiders
- Filings on record
- 15 since 2026-04-28, latest 2026-09-21 16:05
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Hagler Mark Arnold | See Remarks | $577.3K | — |
| Cao Sean Wuxiong | See Remarks, Dir | — | $122.5K |
| Xu Cong Claire | SVP, Clinical Development | — | $20.4K |
| Dennis Phillip Andrew | Chief Medical Off | — | $11.4K |
| Lenz Robert A. | Dir | — | — |
Transactions 15
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-21 16:05 | 2026-09-17 | NBP | Dennis Phillip Andrew | Chief Medical Off | M - OptEx | — | +23.7K | 181.6K | +15% | — |
| D | 2026-09-21 16:05 | 2026-09-18 | NBP | Dennis Phillip Andrew | Chief Medical Off | S - Sale+OE | $0.71 | -8,209 | 173.4K | -5% | -$5,828 |
| 2026-09-11 16:30 | 2026-09-09 | NBP | Cao Sean Wuxiong | Chief Bus. Development Off | S - Sale | $0.74 | -108.0K | 266.5K | -29% | -$79.9K | |
| DM | 2026-09-08 17:51 | 2026-09-03 | NBP | Cao Sean Wuxiong | Chief Bus. Development Off | M - OptEx | — | +339.4K | 374.4K | +968% | — |
| D | 2026-09-01 18:00 | 2026-08-30 | NBP | Xu Cong Claire | EVP, Clinical Development | M - OptEx | — | +9,382 | 307.5K | +3% | — |
| D | 2026-09-01 18:00 | 2026-08-31 | NBP | Xu Cong Claire | EVP, Clinical Development | S - Sale+OE | $0.79 | -3,282 | 304.2K | -1% | -$2,593 |
| D | 2026-08-25 16:15 | 2026-08-22 | NBP | Lenz Robert A. | Dir | M - OptEx | — | +17.2K | 17.2K | New | — |
| D | 2026-07-07 19:50 | 2026-07-04 | NBP | Xu Cong Claire | SVP, Clinical Development | M - OptEx | — | +12.4K | 302.6K | +4% | — |
| D | 2026-07-07 19:50 | 2026-07-06 | NBP | Xu Cong Claire | SVP, Clinical Development | S - Sale+OE | $0.89 | -4,485 | 298.1K | -1% | -$3,992 |
| D | 2026-06-22 17:23 | 2026-06-17 | NBP | Dennis Phillip Andrew | Chief Medical Off | M - OptEx | — | +23.7K | 166.4K | +17% | — |
| D | 2026-06-22 17:23 | 2026-06-18 | NBP | Dennis Phillip Andrew | Chief Medical Off | S - Sale+OE | $0.66 | -8,494 | 157.9K | -5% | -$5,606 |
| D | 2026-06-02 18:46 | 2026-05-30 | NBP | Xu Cong Claire | SVP, Clinical Development | M - OptEx | — | +9,382 | 293.6K | +3% | — |
| D | 2026-06-02 18:46 | 2026-06-01 | NBP | Xu Cong Claire | SVP, Clinical Development | S - Sale+OE | $3.94 | -3,494 | 290.2K | -1% | -$13.8K |
| 2026-05-18 16:05 | 2026-05-14 | NBP | Cao Sean Wuxiong | See Remarks, Dir | S - Sale | $1.99 | -21.4K | 35.1K | -38% | -$42.6K | |
| 2026-04-28 16:05 | 2026-04-24 | NBP | Hagler Mark Arnold | See Remarks | P - Purchase | $2.51 | +230.0K | 230.0K | New | +$577.3K |
Purchase Sale Sale after option exercise All abbreviations